Concert Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs.

Biotechnology

Pharmaceutical

Concert Pharmaceuticals

Roger D. Tung

Karen Merrill

Kristine Hogan

Bob Zelle

Ken Goldenberg (Mitch)

Christopher L. Brummel

Nabil Uddin

Jeffrey A. Munsie

K. Mitch Goldenberg

Cameron J. Cowden

Christine Boisclair

Justine E. Koenigsberg

James V. Cassella

Nancy Stuart

Research and Development

Leadership Team

Teams at Concert Pharmaceuticals

Research and Development

Leadership Team